Home LiteratureArticle Details
PMID: 7734854 Published · ppublish English Journal Article

Post-translational modifications distinguish cell surface from Golgi-retained beta 1,4 galactosyltransferase molecules. Golgi localization involves active retention.

Glycobiology ·Vol. 4 ·No. 6 ·1994-12-00 ·Pages 917-28

Teasdale RD, Matheson F, Gleeson PA

Abstract

beta 1,4 Galactosyltransferase (GalT) is a membrane-bound enzyme localized predominantly to the trans-Golgi cisternae. Our previous studies have shown that the transmembrane domain of bovine GalT plays a critical role in Golgi localization (Teasdale, R.D., D'Agostaro, G. and Gleeson, P.A., J. Biol. Chem., 267, 4084-4096, 1992). Here we have compared the localization and post-translational modifications of full-length bovine GalT with a GalT/hybrid molecule where the transmembrane domain of GalT was replaced with that of the transferrin receptor. GalT/hybrid molecules were expressed on the surface of transfected cells; however, differences were observed in the distribution of the hybrid molecules between transfected COS and murine L cells. In transfected COS cells, the GalT/hybrid protein was expressed efficiently at the cell surface, with little Golgi-localized material, whereas in stable murine L cells, which expressed lower levels of the construct, hybrid molecules were detected both at the cell surface and within the Golgi apparatus. Expression of the GalT constructs in either COS or L cells produced two glycoprotein products which differed in molecular mass by 7 kDa. The difference in size between the two products is due to post-translational modifications which are inhibited by brefeldin A and are therefore likely to occur in the trans-Golgi network (TGN). Very little of the high-molecular-weight species was detected for full-length GalT, whereas it was a major product for the GalT/hybrid protein. Only the higher molecular weight species was expressed at the cell surface. Thus, this additional 7 kDa post-translational modification distinguishes molecules retained within the Golgi apparatus (lower M(r) species) from those transported through the TGN to the cell surface. These studies indicate that (i) the level of expression influences the intracellular distribution of GalT/hybrid molecules and (ii) the localization of full-length GalT involves active retention within the Golgi stack, and not retrieval from later compartments. After treatment of membrane preparations from stable L cell clones with a heterobifunctional cross-linking agent, full-length bovine GalT molecules were found almost exclusively as high-molecular-weight aggregates, suggesting that GalT exists as an oligomer or aggregate. This ability to oligomerize may be a requirement for Golgi retention.

MeSH Terms
Animals Biological Transport, Active Carbohydrate Sequence Cattle Cell Line Cell Membrane/enzymology Cross-Linking Reagents Glycosylation Golgi Apparatus/enzymology L Cells Mice Molecular Sequence Data N-Acetyllactosamine Synthase/chemistry,genetics,metabolism Polysaccharides/chemistry,metabolism Protein Conformation Protein Processing, Post-Translational Receptors, Transferrin/chemistry,genetics,metabolism Recombinant Fusion Proteins/chemistry,genetics,metabolism Transfection
Chemicals
Cross-Linking Reagents Polysaccharides Receptors, Transferrin Recombinant Fusion Proteins N-Acetyllactosamine Synthase
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Teasdale R D
Department of Pathology and Immunology, Monash University Medical School, Alfred Hospital, Melbourne, Victoria, Australia.
Matheson F
Gleeson P A
Article Info
Journal
Glycobiology
Abbr.
Glycobiology
ISSN
0959-6658
Published
1994-12-00
Pages
917-28
Language
English
Region
England
NLM ID
9104124
PMCID
PMC7108631
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]